Brief: PolarityTE Says SkinTE Met Primary And Secondary Endpoints In Final Analysis

RegenETP,

28/07/2021 13:07

July 28 (Reuters) - PolarityTE Inc  PTE.O :
    * POLARITYTE INC - SKINTE MET PRIMARY AND SECONDARY
ENDPOINTS IN
FINAL ANALYSIS FROM DIABETIC FOOT ULCER TRIAL
    * POLARITYTE INC - ANNOUNCES COMPLETION OF STUDY EVALUATING
SKINTE
FOR TREATMENT OF VENOUS LEG ULCERS
    * POLARITYTE INC - DATA INCLUDED IN INVESTIGATIONAL NEW DRUG
APPLICATION SUBMITTED ON JULY 23, 2021

Source text for Eikon:  ID:nBwbdqNLMa 
Further company coverage:  PTE.O 

 ((Reuters.Briefs@thomsonreuters.com;))